Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of potentially druggable molecular alterations in skin adnexal malignancies

30 Apr 2019

Abstract excerpt

Skin adnexal cancers (SAC) are a heterogeneous group of rare malignancies with histological differentiation towards epithelial adnexa, which lack effective systemic treatments. The aim of this work is to identify any potentially druggable genomic alterations for possible targeted therapies. Cases of primary or recurrent/metastatic (RM) SAC between 2002 and 2014 were identified by searching the institutional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Lesions and Carcinomas
Share to Cancer and Skin Lesions
Share to Nonmelanoma Skin Cancer Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31038235
DOI: 10.1111/1346-8138.14889

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of potentially druggable molecular alterations in skin adnexal malignanciesPMID 31038235Read ↗

Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high-throughput sequencing approach.Semantic proximity Read ↗

Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer.Semantic proximity Read ↗

A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.Semantic proximity Read ↗

Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma.Semantic proximity Read ↗

Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.Semantic proximity Read ↗

Genomic profiling and personalized treatment strategies for skin malignancies: findings from the center for cancer genomics and advanced therapeutics databaseSemantic proximity Read ↗

Mutational profile of atypical fibroxanthoma and pleomorphic dermal sarcoma further expands the spectrum of genomic alterations in rare cutaneous neoplasms.Semantic proximity Read ↗

Molecular profiling of a primary cutaneous signet-ring cell/histiocytoid carcinoma of the eyelid.Semantic proximity Read ↗

Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.Semantic proximity Read ↗

A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.Semantic proximity Read ↗

Functional Personalized Treatment of Metastatic PorocarcinomaSemantic proximity Read ↗

Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.